ScienceDaily: Health & Medicine News |
- Vitamin E intake critical during 'the first 1,000 days'
- Brain development in schizophrenia strays from normal path
- Hypersensitivity to non-painful events may be part of pathology in fibromyalgia
- Cheaper alternative to licensed drug for treating eye disease has similar side-effects
- Schizophrenia not a single disease but multiple genetically distinct disorders
- Walking or cycling to work improves wellbeing, researchers find
| Vitamin E intake critical during 'the first 1,000 days' Posted: 15 Sep 2014 05:39 AM PDT Amid conflicting reports about the need for vitamin E and how much is enough, a new analysis published today suggests that adequate levels of this essential micronutrient are especially critical for the very young, the elderly, and women who are or may become pregnant. |
| Brain development in schizophrenia strays from normal path Posted: 15 Sep 2014 05:37 AM PDT Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability. The normal path for brain development is determined by the combined effects of a complex network of genes and a wide range of environmental factors. However, longitudinal brain imaging studies in both healthy and patient populations are required in order to map the disturbances in brain structures as they emerge, researchers say. |
| Hypersensitivity to non-painful events may be part of pathology in fibromyalgia Posted: 15 Sep 2014 05:37 AM PDT New research shows that patients with fibromyalgia have hypersensitivity to non-painful events based on images of the patients' brains, which show reduced activation in primary sensory regions and increased activation in sensory integration areas. Findings suggest that brain abnormalities in response to non-painful sensory stimulation may cause the increased unpleasantness that patients experience in response to daily visual, auditory and tactile stimulation. |
| Cheaper alternative to licensed drug for treating eye disease has similar side-effects Posted: 15 Sep 2014 05:37 AM PDT Health policies that favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of new research. Investigators reviewed the results of studies that compared the safety of two drugs used for treating age-related macular degeneration, ranibizumab and bevacizumab. Contrary to what was argued by some experts, the review has found that the cheaper drug, bevacizumab, does not appear to increase deaths or serious side-effects compared with ranibizumab in people with neovascular age-related macular degeneration. |
| Schizophrenia not a single disease but multiple genetically distinct disorders Posted: 15 Sep 2014 05:35 AM PDT Schizophrenia isn't a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms, research shows. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness. |
| Walking or cycling to work improves wellbeing, researchers find Posted: 14 Sep 2014 06:10 PM PDT Walking or cycling to work is better for people's mental health than driving to work, according to new research by health economists. A report reveals that people who stopped driving and started walking or cycling to work benefited from improved wellbeing. In particular, active commuters felt better able to concentrate and were less under strain than if they traveled by car. |
| You are subscribed to email updates from Health & Medicine News -- ScienceDaily To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
ليست هناك تعليقات:
إرسال تعليق